Here is why Colgate-Palmolive (CL) is Among the Best Oversold Blue Chip Stocks to Buy

Colgate-Palmolive Company (NYSE:CL) is one of the 12 Oversold Blue Chip Stocks to Buy According to Analysts. On April 10, 2026, BofA analyst Peter Galbo lowered the price target on Colgate-Palmolive Company (NYSE:CL) to $102 from $105 and maintained a Buy rating ahead of Q1 results. Peter Galbo said the firm updated its estimates for organic sales and FY26 EPS to reflect delayed launch timing for Optic White in North America, which impacts near-term consumption, as well as a more conservative view on gross margins given rising oil-related input costs.

On April 9, 2026, RBC Capital lowered its price target on Colgate-Palmolive Company (NYSE:CL) to $102 from $104 and maintained an Outperform rating as part of a broader Q1 preview across consumer staples. RBC said the March quarter is expected to be stable but still characterized by a sluggish top-line environment, with investor focus shifting to forward guidance amid inflationary pressures and lingering effects from the Middle East conflict, despite the recent ceasefire.

Last month, Colgate-Palmolive Company (NYSE:CL) announced that Christopher Boerner, CEO of Bristol-Myers Squibb, has been elected to its board of directors.

Colgate-Palmolive Company (NYSE:CL) manufactures and sells consumer products globally.

While we acknowledge the risk and potential of CL as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than CL and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. 

Disclosure: None. Follow Insider Monkey on Google News.